Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs

Glycogen storage disease type Ia (GSDIa) is caused by defective glucose-6-phosphatase, a key enzyme in carbohydrate metabolism. Affected individuals cannot release glucose during fasting and accumulate excess glycogen and fat in the liver and kidney, putting them at risk of severe hypoglycaemia and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Terry G. J. Derks, David F. Rodriguez-Buritica, Ayesha Ahmad, Foekje de Boer, María L. Couce, Sarah C. Grünert, Philippe Labrune, Nerea López Maldonado, Carolina Fischinger Moura de Souza, Rebecca Riba-Wolman, Alessandro Rossi, Heather Saavedra, Rupal Naik Gupta, Vassili Valayannopoulos, John Mitchell
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/49373e0a313c4a1bbb2b3940a73fdda6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49373e0a313c4a1bbb2b3940a73fdda6
record_format dspace
spelling oai:doaj.org-article:49373e0a313c4a1bbb2b3940a73fdda62021-11-25T18:34:27ZGlycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs10.3390/nu131138282072-6643https://doaj.org/article/49373e0a313c4a1bbb2b3940a73fdda62021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3828https://doaj.org/toc/2072-6643Glycogen storage disease type Ia (GSDIa) is caused by defective glucose-6-phosphatase, a key enzyme in carbohydrate metabolism. Affected individuals cannot release glucose during fasting and accumulate excess glycogen and fat in the liver and kidney, putting them at risk of severe hypoglycaemia and secondary metabolic perturbations. Good glycaemic/metabolic control through strict dietary treatment and regular doses of uncooked cornstarch (UCCS) is essential for preventing hypoglycaemia and long-term complications. Dietary treatment has improved the prognosis for patients with GSDIa; however, the disease itself, its management and monitoring have significant physical, psychological and psychosocial burden on individuals and parents/caregivers. Hypoglycaemia risk persists if a single dose of UCCS is delayed/missed or in cases of gastrointestinal intolerance. UCCS therapy is imprecise, does not treat the cause of disease, may trigger secondary metabolic manifestations and may not prevent long-term complications. We review the importance of and challenges associated with achieving good glycaemic/metabolic control in individuals with GSDIa and how this should be balanced with age-specific psychosocial development towards independence, management of anxiety and preservation of quality of life (QoL). The unmet need for treatment strategies that address the cause of disease, restore glucose homeostasis, reduce the risk of hypoglycaemia/secondary metabolic perturbations and improve QoL is also discussed.Terry G. J. DerksDavid F. Rodriguez-BuriticaAyesha AhmadFoekje de BoerMaría L. CouceSarah C. GrünertPhilippe LabruneNerea López MaldonadoCarolina Fischinger Moura de SouzaRebecca Riba-WolmanAlessandro RossiHeather SaavedraRupal Naik GuptaVassili ValayannopoulosJohn MitchellMDPI AGarticleglycogen storage disease type Iadietary treatmentuncooked cornstarchburden of diseaseunmet needlong-term complicationsNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3828, p 3828 (2021)
institution DOAJ
collection DOAJ
language EN
topic glycogen storage disease type Ia
dietary treatment
uncooked cornstarch
burden of disease
unmet need
long-term complications
Nutrition. Foods and food supply
TX341-641
spellingShingle glycogen storage disease type Ia
dietary treatment
uncooked cornstarch
burden of disease
unmet need
long-term complications
Nutrition. Foods and food supply
TX341-641
Terry G. J. Derks
David F. Rodriguez-Buritica
Ayesha Ahmad
Foekje de Boer
María L. Couce
Sarah C. Grünert
Philippe Labrune
Nerea López Maldonado
Carolina Fischinger Moura de Souza
Rebecca Riba-Wolman
Alessandro Rossi
Heather Saavedra
Rupal Naik Gupta
Vassili Valayannopoulos
John Mitchell
Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
description Glycogen storage disease type Ia (GSDIa) is caused by defective glucose-6-phosphatase, a key enzyme in carbohydrate metabolism. Affected individuals cannot release glucose during fasting and accumulate excess glycogen and fat in the liver and kidney, putting them at risk of severe hypoglycaemia and secondary metabolic perturbations. Good glycaemic/metabolic control through strict dietary treatment and regular doses of uncooked cornstarch (UCCS) is essential for preventing hypoglycaemia and long-term complications. Dietary treatment has improved the prognosis for patients with GSDIa; however, the disease itself, its management and monitoring have significant physical, psychological and psychosocial burden on individuals and parents/caregivers. Hypoglycaemia risk persists if a single dose of UCCS is delayed/missed or in cases of gastrointestinal intolerance. UCCS therapy is imprecise, does not treat the cause of disease, may trigger secondary metabolic manifestations and may not prevent long-term complications. We review the importance of and challenges associated with achieving good glycaemic/metabolic control in individuals with GSDIa and how this should be balanced with age-specific psychosocial development towards independence, management of anxiety and preservation of quality of life (QoL). The unmet need for treatment strategies that address the cause of disease, restore glucose homeostasis, reduce the risk of hypoglycaemia/secondary metabolic perturbations and improve QoL is also discussed.
format article
author Terry G. J. Derks
David F. Rodriguez-Buritica
Ayesha Ahmad
Foekje de Boer
María L. Couce
Sarah C. Grünert
Philippe Labrune
Nerea López Maldonado
Carolina Fischinger Moura de Souza
Rebecca Riba-Wolman
Alessandro Rossi
Heather Saavedra
Rupal Naik Gupta
Vassili Valayannopoulos
John Mitchell
author_facet Terry G. J. Derks
David F. Rodriguez-Buritica
Ayesha Ahmad
Foekje de Boer
María L. Couce
Sarah C. Grünert
Philippe Labrune
Nerea López Maldonado
Carolina Fischinger Moura de Souza
Rebecca Riba-Wolman
Alessandro Rossi
Heather Saavedra
Rupal Naik Gupta
Vassili Valayannopoulos
John Mitchell
author_sort Terry G. J. Derks
title Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
title_short Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
title_full Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
title_fullStr Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
title_full_unstemmed Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
title_sort glycogen storage disease type ia: current management options, burden and unmet needs
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/49373e0a313c4a1bbb2b3940a73fdda6
work_keys_str_mv AT terrygjderks glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT davidfrodriguezburitica glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT ayeshaahmad glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT foekjedeboer glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT marialcouce glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT sarahcgrunert glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT philippelabrune glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT nerealopezmaldonado glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT carolinafischingermouradesouza glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT rebeccaribawolman glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT alessandrorossi glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT heathersaavedra glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT rupalnaikgupta glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT vassilivalayannopoulos glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
AT johnmitchell glycogenstoragediseasetypeiacurrentmanagementoptionsburdenandunmetneeds
_version_ 1718410950707511296